Response to Letter to the Editor From Kawaguchi: "Cardiovascular Safety of Romosozumab vs PTH Analogs for Osteoporosis Treatment: A Propensity Score Matched Cohort Study".

J Clin Endocrinol Metab

Department of Internal Medicine, Faculty of Medicine, Osteoporosis Center, Hadassah Medical Center, The Hebrew University of Jerusalem, 9124001 Jerusalem, Israel.

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgae348DOI Listing

Publication Analysis

Top Keywords

response letter
4
letter editor
4
editor kawaguchi
4
kawaguchi "cardiovascular
4
"cardiovascular safety
4
safety romosozumab
4
romosozumab pth
4
pth analogs
4
analogs osteoporosis
4
osteoporosis treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!